Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stran & Company (SWAG) Cash & Equivalents (2020 - 2025)

Stran & Company's Cash & Equivalents history spans 6 years, with the latest figure at $6.7 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 33.27% year-over-year to $6.7 million; the TTM value through Sep 2025 reached $6.7 million, down 33.27%, while the annual FY2024 figure was $9.4 million, 16.12% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $6.7 million at Stran & Company, down from $13.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $40.0 million in Q1 2022 and bottomed at $797428.0 in Q3 2021.
  • The 5-year median for Cash & Equivalents is $10.7 million (2023), against an average of $13.9 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 4879.13% in 2021 before it plummeted 73.34% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $32.2 million in 2021, then crashed by 52.67% to $15.3 million in 2022, then crashed by 47.17% to $8.1 million in 2023, then rose by 16.12% to $9.4 million in 2024, then dropped by 28.44% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for SWAG's Cash & Equivalents are $6.7 million (Q3 2025), $13.1 million (Q2 2025), and $4.2 million (Q1 2025).